Early Flu Outbreak Shifts Demand to Ibuprofen-Based Cold Remedies as Hanmi Leads Market
With wide daily temperature fluctuations causing seasonal influenza to spread nearly a month earlier than usual in South Korea, pharmacies are seeing...
Search results for "Hanmi Pharmaceutical"
Hanmi Group Unveils ‘Anne’ Character to Unify Popular OTC Brand Lineup
Sore-throat spray "Mok-Anne" and artificial tear formula "Nun-Anne"—two familiar over-the-counter products in South Korea—now have a unified brand...
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Hanmi Pharmaceutical’s Paltan Smart Plant Cuts Drug Stockouts 57% Following Reorganization
Stockout cases have dropped sharply at Hanmi Pharmaceutical’s primary manufacturing base for synthetic drugs.
[Reporter’s Notebook] Hanmi Group’s Internal Feuds Keep Invoking the ‘Lim Sung-ki Spirit.’ It Must Apply to Everyone
Whenever a control dispute or internal conflict erupts at Hanmi Group, one phrase reliably resurfaces: the “Lim Sung-ki...
Hanmi Control Dispute Reignites as Court Freezes 10 Billion Won in Lim Ju-hyun’s Shares
The "four-party alliance" formed to stabilize management control at Hanmi Pharmaceutical Group has descended into open...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care
Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.